# Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones

> **NCT00599664** · PHASE1 · COMPLETED · sponsor: **Omeros Corporation** · enrollment: 11 (actual)

## Conditions studied

- Urinary Calculi
- Urinary Stones
- Urinary Tract Stones

## Interventions

- **DRUG:** OMS201
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT00599664
- **Lead sponsor:** Omeros Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** —
- **Final completion:** 2008-09
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2010-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599664, "Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00599664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*